August 12, 2019
CASE STUDY: Complex protocol requirements and diligent study monitoring
Neox was chosen to perform a global clinical evaluation of reduced cardiac ejection fraction, and the protocol required highly sophisticated examination techniques. Not confined to the restrictions of a challenging timeline, we quickly identified and evaluated suitable sites. We set up a thorough training program and shortly initiated the appropriate sites. Due to our efforts, we had the second-best enrollment among all countries involved.
The clinical data collected by our highly experienced CRAs and the pre-trained sites were of high quality, resulting in the lowest protocol deviation in the entire trial. Our excellent performance in patient recruitment, site training, and monitoring makes us a preferred partner for our repeat clients.